Dangers of OxyContin Presented to the FDA

With the number of people abusing and becoming addicted to OxyContin rising at an alarming rate, addiction experts are warning the FDA that action needs to be taken to address the problem.

Steve Hayes, director of Novus Medical Detox Center, and Larry Golbom, host of Prescription Addiction Radio, testified before the FDA on May 27, 2009 about the need to impose Risk Evaluation Mitigation Strategies on opioids like OxyContin.

During the testimony, Golbom explained that the molecular structure of oxycodone (the active ingredient of OxyContin) is nearly identical to heroin and that the effects are practically the same. He also stated that Purdue Pharma, the manufacturer of OxyContin, has been convicted of lying to the public and doctors about the addictive qualities of OxyContin. In addition, he introduced the website www.BanOxycontin.com and read testimonies from people who have been directly affected by OxyContin, including losing loved ones because of it. … Continue Reading